AwesomeCapital
Search This Blog
Monday, February 11, 2019
JMP Upgrades Proteon Therapeutics (PRTO) to Market Outperform
JMP Securities analyst Jason Butler upgraded Proteon Therapeutics (NASDAQ: PRTO) from Market Perform to Market Outperform
https://www.streetinsider.com/Analyst+Comments/JMP+Securities+Upgrades+Proteon+Therapeutics+%28PRTO%29+to+Market+Outperform/15103232.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.